Lyn Jones in

Lyn Jones

Login to view DISC.
Professor of the Practice at Harvard Medical School
📍 Boston, Massachusetts, United States

Dr. Lyn Jones is a Principal Investigator at the Dana-Farber Cancer Institute and a Professor of the Practice at Harvard Medical School. His work focuses on advancing next-generation covalent chemical biology to expand the druggable proteome, with a PhD from the University of Nottingham.

He is a Fellow of the Learned Society of Wales, an honor recognizing his contributions to advancing novel therapeutic modalities. This prestigious appointment suggests a strong connection to or heritage from Wales, reflecting a significant aspect of his background outside his immediate scientific work.

Unique fact: Dr. Jones pioneered novel molecular glue drug discovery modalities, leading to the creation of three spin-out companies.

Read the full overview →
Experience
29 Years
Current Role
Professor of the Practice
Job Level
Senior
Location
Boston, Massachusetts, United States
Personality Overview

How Lyn shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Lyn cares about

Covalent Drug Discovery
His research at Dana-Farber and Harvard is centered on using next-generation covalent chemical biology to expand the druggable proteome.
Protein Degradation
As former Chief Scientist for the Center for Protein Degradation, he pioneered molecular glue modalities and recently published preprints on the covalent remodeling of cereblon.
+5 more topics Login to view topics
Career

Work history

2-2026
Professor of the Practice
Harvard Medical School
6-2025
Principal Investigator
Dana-Farber Cancer Institute
9-2019 - 5-2025
Chief Scientist, Center for Protein Degradation
Dana-Farber Cancer Institute
4-2017 - 8-2019
Head of Chemistry and Chemical Biology, Vice President
Jnana Therapeutics
9-2011 - 3-2017
Head of Rare Diseases Chemistry. Head of Chemical Biology (I&I and Rare Diseases)
Pfizer
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1995 - 1998
PhD
University of Nottingham
1991 - 1995
BSc (Hons)
University of Bath
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Harvard Medical School Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Lyn. Free, 10 seconds.